I am a clinician scientist with training as a movement disorder neurologist and deep brain stimulation specialist. My primary research focus is the development of neuromodulation therapies for freezing of gait (FoG) in patients with Parkinson’s disease (PD). I initiated a research program utilizing diffusion kurtosis tractography to characterize the locomotor pathway changes in FoG patients, and developing surrogate markers of FoG severity through gait analysis. This research has been expanded to focus on differences in the pathways in patients that are dopa un-responsive, and correlating these changes with findings on gait analysis. I am experienced in the design and implementation of clinical trials through a number of investigator initiated pilot trials of therapeutics and participation in national consortia led multicenter clinical trials, including investigation for multiple neuromodulation modalities.